DiaMedica Therapeutics Inc. (DMAC) NASDAQ
$2.59 0.15 (6.15%)
Market Cap: $98.30M
As of 12/01/23 04:00 PM EST. Market closed.
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ
$2.59
0.15 (6.15%)
Market Cap: $98.30M
As of 12/01/23 04:00 PM EST. Market closed.
Add to Portfolio
diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit ... read more
diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
60
Address
.
PRICE CHART FOR DIAMEDICA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.37
Previous Close
$2.44
Days Range
$2.34 - $2.59
52 week range
$1.27 - $4.75
Volume
31,243
Avg. Volume (30 days)
58,059
Market Cap
$98.30M
Dividend Yield
-
P/E
-
Shares Outstanding
37,953,711
Open
$2.37
Previous Close
$2.44
Days Range
$2.34 - $2.59
52 week range
$1.27 - $4.75
Volume
31,243
Avg. Volume (30 days)
58,059
Market Cap
$98.30M
Dividend Yield
-
P/E
-
Shares Outstanding
37,953,711
FINANCIAL STATEMENTS FOR DIAMEDICA THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR DIAMEDICA THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Wambeke David J. | Chief Business Officer | Nov 16, 2023 | Buy | $2.46 | 20,000 | 49,200 | 527,114 | Nov 16, 2023, 04:37 PM |
| Von Koch Thomas | 10% Owner | Jun 23, 2023 | Buy | $3.40 | 1,470,588 | 4,999,999 | 4,326,435 | Jun 27, 2023, 04:11 PM |
| Giuffre Randall Michael | Director | Jun 23, 2023 | Buy | $3.91 | 65,000 | 254,150 | 360,355 | Jun 26, 2023, 04:42 PM |
| Pauls Dietrich John | President and CEO | Jun 23, 2023 | Buy | $3.91 | 12,787 | 49,997 | 68,591 | Jun 26, 2023, 04:34 PM |
| Semba Charles Pauling | Director | Jun 23, 2023 | Buy | $3.91 | 12,787 | 49,997 | 29,943 | Jun 26, 2023, 04:26 PM |
| Kellen Scott | CFO and Secretary | Jun 23, 2023 | Buy | $3.91 | 10,000 | 39,100 | 32,290 | Jun 26, 2023, 04:21 PM |
| Wambeke David J. | Chief Business Officer | Jun 23, 2023 | Buy | $3.91 | 38,364 | 150,003 | 507,114 | Jun 26, 2023, 04:14 PM |
| Pilnik Richard D. | Director | Jun 23, 2023 | Buy | $3.91 | 38,363 | 149,999 | 248,245 | Jun 26, 2023, 04:03 PM |
| Wambeke David J. | Chief Business Officer | Apr 10, 2023 | Buy | $1.60 | 468,750 | 750,000 | 468,750 | Apr 11, 2023, 05:40 PM |
| Giuffre Randall Michael | Director | Jan 03, 2023 | Option Exercise | $1.53 | 35,130 | 53,749 | 295,355 | Jan 03, 2023, 04:43 PM |
| Burroughs Amy L. | Director | Jan 03, 2023 | Option Exercise | $1.53 | 17,156 | 26,249 | 73,288 | Jan 03, 2023, 04:36 PM |
| Semba Charles Pauling | Director | Jan 03, 2023 | Option Exercise | $1.53 | 17,156 | 26,249 | 17,156 | Jan 03, 2023, 04:25 PM |
| Pilnik Richard D. | Director | Jan 03, 2023 | Option Exercise | $1.53 | 55,555 | 84,999 | 209,882 | Jan 03, 2023, 04:19 PM |
| Giuffre Randall Michael | Director | Dec 08, 2022 | Buy | $1.40 | 20,000 | 28,000 | 223,146 | Dec 12, 2022, 04:34 PM |
| Giuffre Randall Michael | Director | Dec 09, 2022 | Buy | $1.43 | 37,079 | 53,023 | 260,225 | Dec 12, 2022, 04:34 PM |
| Giuffre Randall Michael | Director | Dec 07, 2022 | Buy | $1.40 | 22,574 | 31,604 | 203,146 | Dec 08, 2022, 04:55 PM |
| Giuffre Randall Michael | Director | Dec 06, 2022 | Buy | $1.35 | 2,300 | 3,105 | 180,572 | Dec 08, 2022, 04:55 PM |
| Von Koch Thomas | 10% Owner | Dec 02, 2022 | Buy | $1.24 | 2,855,847 | 3,526,971 | 2,855,847 | Dec 06, 2022, 03:19 PM |
| Von Koch Thomas | 10% Owner | Dec 02, 2022 | Sale | $1.24 | 2,855,847 | 3,526,971 | 0 | Dec 06, 2022, 03:19 PM |
| Pilnik Richard D. | Director | Dec 05, 2022 | Buy | $1.39 | 35,000 | 48,492 | 154,327 | Dec 05, 2022, 04:16 PM |
| Giuffre Randall Michael | Director | Dec 01, 2022 | Buy | $1.19 | 819 | 975 | 178,272 | Dec 05, 2022, 04:08 PM |
| Giuffre Randall Michael | Director | Dec 01, 2022 | Buy | $1.20 | 46,133 | 55,360 | 177,453 | Dec 01, 2022, 05:11 PM |
| Giuffre Randall Michael | Director | Nov 30, 2022 | Buy | $1.19 | 2,970 | 3,534 | 131,320 | Dec 01, 2022, 05:11 PM |
| Giuffre Randall Michael | Director | Nov 29, 2022 | Buy | $1.19 | 18,125 | 21,569 | 128,350 | Dec 01, 2022, 05:11 PM |
| Pauls Dietrich John | President and CEO | Nov 16, 2022 | Buy | $1.21 | 20,000 | 24,200 | 55,804 | Nov 16, 2022, 08:56 PM |
| Von Koch Thomas | 10% Owner | Jul 08, 2022 | Buy | $1.33 | 207,974 | 275,898 | 2,855,827 | Jul 21, 2022, 01:06 PM |
| Burroughs Amy L. | Director | Jan 03, 2022 | Option Exercise | $3.58 | 11,182 | 40,032 | 56,132 | Jan 03, 2022, 04:39 PM |
| Pilnik Richard D. | Director | Jan 03, 2022 | Option Exercise | $3.58 | 23,762 | 85,068 | 119,327 | Jan 03, 2022, 04:26 PM |
| Parsons James T. | Director | Jan 03, 2022 | Option Exercise | $3.58 | 16,773 | 60,047 | 38,509 | Jan 03, 2022, 04:21 PM |
| Giuffre Randall Michael | Director | Jan 03, 2022 | Option Exercise | $3.58 | 15,026 | 53,793 | 110,225 | Jan 03, 2022, 04:09 PM |
| ALCORN HARRY W JR | SVP, Clinical Operations | Sep 15, 2021 | Buy | $3.80 | 15,000 | 56,960 | 43,582 | Sep 15, 2021, 04:37 PM |
| Burroughs Amy L. | Director | Aug 16, 2021 | Buy | $3.15 | 44,950 | 141,593 | 44,950 | Aug 17, 2021, 04:11 PM |
| Pilnik Richard D. | Director | Aug 16, 2021 | Buy | $3.27 | 15,000 | 49,064 | 95,565 | Aug 17, 2021, 04:05 PM |
| ALCORN HARRY W JR | Senior VP, Clinical Operations | Aug 16, 2021 | Buy | $3.07 | 399 | 1,225 | 399 | Aug 16, 2021, 04:27 PM |
| ALCORN HARRY W JR | Senior VP, Clinical Operations | Aug 16, 2021 | Buy | $3.09 | 20,322 | 62,829 | 28,582 | Aug 16, 2021, 04:27 PM |
| Pauls Dietrich John | President and CEO | Aug 16, 2021 | Buy | $3.14 | 5,000 | 15,700 | 35,804 | Aug 16, 2021, 04:19 PM |
| Kellen Scott | CFO and Secretary | Aug 16, 2021 | Buy | $3.15 | 10,000 | 31,463 | 22,290 | Aug 16, 2021, 04:10 PM |
| Giuffre Randall Michael | Director | Jan 01, 2021 | Option Exercise | $8.23 | 7,441 | 61,239 | 116,029 | Jan 04, 2021, 04:33 PM |
| Parsons James T. | Director | Jan 01, 2021 | Option Exercise | $8.23 | 7,745 | 63,741 | 21,947 | Jan 04, 2021, 04:21 PM |
| Pilnik Richard D. | Director | Jan 01, 2021 | Option Exercise | $8.23 | 9,719 | 79,987 | 80,565 | Jan 04, 2021, 04:12 PM |
| Pilnik Richard D. | Director | Dec 04, 2020 | Buy | $5.37 | 10,000 | 53,697 | 70,846 | Dec 04, 2020, 05:46 PM |
| Giuffre Randall Michael | Director | Nov 20, 2020 | Buy | $4.26 | 15,000 | 63,912 | 108,588 | Nov 23, 2020, 04:22 PM |
| Kellen Scott | CFO and Secretary | Nov 09, 2020 | Buy | $4.19 | 2,000 | 8,387 | 12,290 | Nov 10, 2020, 08:16 AM |
| Giuffre Randall Michael | Director | Jun 01, 2020 | Option Exercise | $4.59 | 7,784 | 35,729 | 93,588 | Jun 02, 2020, 04:59 PM |
| Parsons James T. | Director | Jun 01, 2020 | Option Exercise | $4.59 | 8,102 | 37,188 | 14,202 | Jun 02, 2020, 04:49 PM |
| Pilnik Richard D. | Director | Jun 01, 2020 | Option Exercise | $4.59 | 10,168 | 46,671 | 60,846 | Jun 02, 2020, 04:33 PM |
| Kellen Scott | CFO and Secretary | Aug 19, 2019 | Buy | $2.43 | 3,000 | 7,290 | 10,290 | Aug 19, 2019, 04:24 PM |
| Pilnik Richard D. | Director | Aug 16, 2019 | Buy | $2.56 | 7,840 | 20,039 | 50,678 | Aug 19, 2019, 06:45 AM |
| ALCORN HARRY W JR | Chief Medical Officer | Aug 16, 2019 | Buy | $2.67 | 7,260 | 19,365 | 8,260 | Aug 16, 2019, 04:35 PM |
| Pauls Dietrich John | President and CEO | Aug 16, 2019 | Buy | $2.68 | 1,000 | 2,677 | 30,804 | Aug 16, 2019, 04:31 PM |
| Pilnik Richard D. | Director | May 31, 2019 | Buy | $2.80 | 19,000 | 53,200 | 42,838 | May 31, 2019, 04:11 PM |
| Kellen Scott | CFO and Secretary | May 24, 2019 | Buy | $2.94 | 4,000 | 11,770 | 7,290 | May 28, 2019, 07:17 AM |
| ALCORN HARRY W JR | Chief Medical Officer | Mar 27, 2019 | Buy | $4.46 | 150 | 668 | 1,150 | Mar 29, 2019, 04:15 PM |
| Xiao Zhenyu | Director | Dec 11, 2018 | Buy | $4.00 | 3,250 | 13,000 | 7,100 | Dec 11, 2018, 04:48 PM |
| Verdoorn Todd A. | Chief Scientific Officer | Dec 11, 2018 | Buy | $4.00 | 1,000 | 4,000 | 2,000 | Dec 11, 2018, 04:42 PM |
| Pilnik Richard D. | Director | Dec 11, 2018 | Buy | $4.00 | 6,250 | 25,000 | 23,838 | Dec 11, 2018, 04:37 PM |
| Pauls Dietrich John | President and CEO | Dec 11, 2018 | Buy | $4.00 | 5,000 | 20,000 | 29,804 | Dec 11, 2018, 04:31 PM |
| Parsons James T. | Director | Dec 11, 2018 | Buy | $4.00 | 2,250 | 9,000 | 6,100 | Dec 11, 2018, 04:27 PM |
| Kellen Scott | CFO and Secretary | Dec 11, 2018 | Buy | $4.00 | 1,250 | 5,000 | 3,290 | Dec 11, 2018, 04:22 PM |
| Giuffre Randall Michael | Director | Dec 11, 2018 | Buy | $4.00 | 11,250 | 45,000 | 85,804 | Dec 11, 2018, 04:17 PM |
| ALCORN HARRY W JR | Chief Medical Officer | Dec 11, 2018 | Buy | $4.00 | 1,000 | 4,000 | 1,000 | Dec 11, 2018, 04:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN DIAMEDICA THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 218,778 | 0.00007% | 18.34% | Other |
| BLACKROCK INC. | 101,725 | 0.00001% | 41.45% | Other |
CHANGE IN SHARES OUTSTANDING FOR DIAMEDICA THERAPEUTICS INC
STOCK BUYBACKS FOR DIAMEDICA THERAPEUTICS INC
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
43.51%
4Q
06/30/2022
43.51%
5Q
03/31/2022
43.51%
6Q
BUYBACK ANNOUNCEMENT(S) FOR DIAMEDICA THERAPEUTICS INC
LOADING...